81 results
Page 4 of 5
8-K
EX-99.1
ol4xpri0
9 Aug 18
Viking Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update
12:00am
424B5
1432cf3qgtmaiclgm9
7 Jun 18
Prospectus supplement for primary offering
5:13pm
8-K
EX-1.1
jr5ld462j29 bd
7 Jun 18
Viking Therapeutics Announces Pricing of $67.5 Million Public Offering of Common Stock
1:41pm
424B5
0rgjutxo6av4c8o
6 Jun 18
Prospectus supplement for primary offering
4:11pm
8-K
EX-99.1
vxmjx vlqnno12
9 May 18
Viking Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update
12:00am
424B4
uq6tktnq
8 Apr 16
Prospectus supplement with pricing info
12:00am
10-K
mqne1shb7s4r8tc
8 Mar 16
Annual report
12:00am